These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 21527291)

  • 1. A comparison of brain and behavioral effects of varenicline and nicotine in rats.
    King J; Huang W; Chen W; Heffernan M; Shields J; Rane P; Bircher R; DiFranza JR
    Behav Brain Res; 2011 Sep; 223(1):42-7. PubMed ID: 21527291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological profile of the alpha4beta2 nicotinic acetylcholine receptor partial agonist varenicline, an effective smoking cessation aid.
    Rollema H; Chambers LK; Coe JW; Glowa J; Hurst RS; Lebel LA; Lu Y; Mansbach RS; Mather RJ; Rovetti CC; Sands SB; Schaeffer E; Schulz DW; Tingley FD; Williams KE
    Neuropharmacology; 2007 Mar; 52(3):985-94. PubMed ID: 17157884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of varenicline on the acute and repeated locomotor responses to nicotine in rats.
    Zaniewska M; McCreary AC; Stefański R; Przegaliński E; Filip M
    Synapse; 2008 Dec; 62(12):935-9. PubMed ID: 18798299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of the alpha4beta2 partial agonist varenicline on brain activity and working memory in abstinent smokers.
    Loughead J; Ray R; Wileyto EP; Ruparel K; Sanborn P; Siegel S; Gur RC; Lerman C
    Biol Psychiatry; 2010 Apr; 67(8):715-21. PubMed ID: 20207347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of varenicline on the development and expression of nicotine-induced behavioral sensitization and cross-sensitization in rats.
    Goutier W; Kloeze MB; McCreary AC
    Addict Biol; 2015 Mar; 20(2):248-58. PubMed ID: 24251901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Varenicline and mecamylamine attenuate locomotor sensitization and cross-sensitization induced by nicotine and morphine in mice.
    Biala G; Staniak N
    Pharmacol Biochem Behav; 2010 Aug; 96(2):141-7. PubMed ID: 20451547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The smoking cessation medication varenicline attenuates alcohol and nicotine interactions in the rat mesolimbic dopamine system.
    Ericson M; Löf E; Stomberg R; Söderpalm B
    J Pharmacol Exp Ther; 2009 Apr; 329(1):225-30. PubMed ID: 19126781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The high-affinity nAChR partial agonists varenicline and sazetidine-A exhibit reinforcing properties in rats.
    Paterson NE; Min W; Hackett A; Lowe D; Hanania T; Caldarone B; Ghavami A
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Dec; 34(8):1455-64. PubMed ID: 20708056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain activity and emotional processing in smokers treated with varenicline.
    Loughead J; Ray R; Wileyto EP; Ruparel K; O'Donnell GP; Senecal N; Siegel S; Gur RC; Lerman C
    Addict Biol; 2013 Jul; 18(4):732-8. PubMed ID: 21507156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination treatment with varenicline and nicotine replacement therapy.
    Ebbert JO; Burke MV; Hays JT; Hurt RD
    Nicotine Tob Res; 2009 May; 11(5):572-6. PubMed ID: 19351781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of acetaldehyde on nicotine-induced transmitter levels in young and adult brain areas.
    Sershen H; Shearman E; Fallon S; Chakraborty G; Smiley J; Lajtha A
    Brain Res Bull; 2009 Aug; 79(6):458-62. PubMed ID: 19389462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Varenicline blocks β2*-nAChR-mediated response and activates β4*-nAChR-mediated responses in mice in vivo.
    Ortiz NC; O'Neill HC; Marks MJ; Grady SR
    Nicotine Tob Res; 2012 Jun; 14(6):711-9. PubMed ID: 22241831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High resolution spatial mapping of nicotine action using pharmacologic magnetic resonance imaging.
    Choi JK; Mandeville JB; Chen YI; Kim YR; Jenkins BG
    Synapse; 2006 Aug; 60(2):152-7. PubMed ID: 16715493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Varenicline disrupts prepulse inhibition only in high-inhibitory rats.
    Goktalay T; Buyukuysal S; Uslu G; Coskun AS; Yorgancioglu A; Kayir H; Uzbay T; Goktalay G
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Aug; 53():54-60. PubMed ID: 24632394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenosine (A)(2A)receptor modulation of nicotine-induced locomotor sensitization. A pharmacological and transgenic approach.
    Jastrzębska J; Nowak E; Smaga I; Bystrowska B; Frankowska M; Bader M; Filip M; Fuxe K
    Neuropharmacology; 2014 Jun; 81():318-26. PubMed ID: 24632528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Varenicline increases striatal dopamine D(2/3) receptor binding in rats.
    Crunelle CL; Miller ML; de Bruin K; van den Brink W; Booij J
    Addict Biol; 2009 Sep; 14(4):500-2. PubMed ID: 19650815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prenatal nicotine and/or cocaine differentially alters nicotine-induced sensitization in aging offspring.
    Sobrian SK; Johnston M; Wright J; Kuhn D; Ameis K
    Ann N Y Acad Sci; 2008 Oct; 1139():466-77. PubMed ID: 18991894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dose-dependent and sustained effects of varenicline on dopamine D2/3 receptor availability in rats.
    Crunelle CL; Schulz S; de Bruin K; Miller ML; van den Brink W; Booij J
    Eur Neuropsychopharmacol; 2011 Feb; 21(2):205-10. PubMed ID: 21130610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Divergent functional effects of sazetidine-a and varenicline during nicotine withdrawal.
    Turner JR; Wilkinson DS; Poole RL; Gould TJ; Carlson GC; Blendy JA
    Neuropsychopharmacology; 2013 Sep; 38(10):2035-47. PubMed ID: 23624742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic sazetidine-A maintains anxiolytic effects and slower weight gain following chronic nicotine without maintaining increased density of nicotinic receptors in rodent brain.
    Hussmann GP; DeDominicis KE; Turner JR; Yasuda RP; Klehm J; Forcelli PA; Xiao Y; Richardson JR; Sahibzada N; Wolfe BB; Lindstrom J; Blendy JA; Kellar KJ
    J Neurochem; 2014 May; 129(4):721-31. PubMed ID: 24422997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.